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by reporter assay, nuclear accumulation of β-catenin (Western blotting), or
expression of Axin-2 mRNA. Gene expression analysis of chondrocyte mark-
ers including Col2A1, Col1A1, Col10A1, Aggrecan, Sox9, MMP3, MMP13,
ADAMTS5 was performed by quantitative real time PCR.
Results: Wnt3a induced the activation of both the canonical and the
CaMKII-dependent pathways. More importantly, using a systematic strat-
egy of blockade of the different pathways, we have separated the effects
that are directly dependent on the activation of the canonical pathway,
including proliferation, from those that are non-canonical such as disrup-
tion of the chondrocyte phenotype, as evaluated by downregulation of
differentiation markers, and cell survival. Most importantly we have built
up a model in which, through reciprocal inhibition of these two pathways,
either excessive Wnt3a stimulation or blockade equally leads to cartilage
breakdown.
Conclusions: – Wnt3a can activate either the canonical or the CaMKII-
dependent Wnt signaling pathway in adult human articular chondrocytes
– The β-catenin and the CaMKII-dependent Wnt pathways are reciprocally
inhibitory
– The Wnt3a-dependent canonical and non canonical pathway activation
has distinct outcomes
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Purpose: Alarmins S100A8 and S100A9 are members of the S100 fam-
ily of Ca2+-binding proteins that are associated with inﬂammation and
bone erosion during human rheumatoid arthritis (RA). Recently, we found
that S100A8 and S100A9 are also associated with cartilage degradation
in murine collagenase-induced osteoarthritis (OA). We also showed that
S100A8 and S100A9 stimulate expression and activity of matrix metallopro-
teinases (MMPs) and pro-inﬂammatory cytokines in murine chondrocytes.
We now investigated whether S100A8, S100A9 and/or S100A8/S100A9
complex could also activate human chondrocytes from OA patients and
skew them towards a cartilage breakdown phenotype.
Methods: Cartilage was collected from human OA patients undergoing joint
replacement. Immunostaining was performed on paraﬃn sections of OA
cartilage using antibodies against S100A8 and S100A9 and against VDIPEN
and NITEGE, which are MMP- and A disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS)-induced cartilage breakdown neoepi-
topes. Chondrocytes were isolated from OA cartilage and stimulated with
recombinant S100A8, S100A9, S100A8/A9 heterodimer and/or interleukin
1 beta (IL-1beta). mRNA levels of MMPs, cytokines and cartilage matrix
molecules were determined with RT-qPCR and protein levels of MMP and
cytokine using Luminex.
Results: Immunostaining on OA cartilage showed that both S100A8 and
S100A9 protein were expressed in and around chondrocytes. Furthermore,
immunostaining of breakdown neoepitopes VDIPEN and NITEGE was found
in the same areas as the S100 proteins.
Stimulation of OA chondrocytes with the monomers S100A8 and S100A9
for 24 hours strongly stimulated cartilage degrading molecules like MMPs
and cytokines. mRNA expression of MMP1, -3, -9 and -13 was upregulated
4-, 4-, 3- and 3-fold respectively. Protein levels of MMP1, -3 and -13
were upregulated 234, 27 and 136% respectively. Moreover, particularly
interleukin 6 (IL-6) levels were strongly upregulated on mRNA level (11-
fold) and protein levels reached 5 ng/ml. The catabolic effect of S100A8
and S100A9 was almost comparable to IL-1beta effects, but there was no
additive effect of S100 with IL-1beta, suggesting independent mechanisms.
Apart from stimulating cartilage degradation, S100A8 and S100A9
monomers also inhibited new formation of cartilage matrix molecules.
mRNA levels of aggrecan and collagen type II were signiﬁcantly decreased
2- to 3-fold, suggesting that these proteins inhibit repair.
In contrast to the monomers, the heterodimer S100A8/A9 neither had effect
on cartilage degradation nor on cartilage matrix production.
Conclusions: S100A8 and S100A9 expression is found in areas with car-
tilage breakdown in OA cartilage. Moreover these proteins inhibit new
formation of matrix molecules and stimulate production of cartilage
degrading molecules thereby skewing chondrocytes towards a cartilage
breakdown phenotype.
S100A8 and/or S100A9 may serve as therapeutic targets for the treatment
of cartilage damage during OA.
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Purpose: TGF- beta is a powerful anabolic factor for chondrocytes and plays
an important role by enhancing cartilage repair. Oxidative stress and mito-
chondrial damage have been found to promote cell death, functional failure
and degeneration. There is a growing body of evidence that mitochondrial
dysfunction is present during the progression of osteoarthritis. The purpose
of the present study was to evaluate whether TGF-beta enhances cartilage
repair through the prevention of mitochondrial DNA damage and dys-
function in human OA chondrocytes subjected to experimentally-induced
oxidative stress.
Methods: Primary OA chondrocytes cultures, generated from cartilage from
patients undergoing total knee replacement, were exposed for 30 min to
reactive oxygen species (ROS) generators xanthine oxidase/hypoxanthine
or peroxynitrite. Some cells were pre-incubated with 5 ng/ml of TGF-beta
for 24 h prior to treatment. In some experiments cells were incubated
for 48 h with IL-1 beta or TNF-alpha alone or in combination with TGF-
beta. Following exposure, cells were immediately lysed for DNA isolation,
protein isolation, ATP analysis, or replenished with normal growth media
and left for recovery and then analyzed. Mitochondrial dysfunction was
assessed in terms of mitochondrial DNA damage (Quantitative Southern
blot analysis), ATP content (Bioluminescence kit), mitochondrial proteins
levels (Western blot). Cell viability and apoptosis were evaluated by ﬂow
cytometry. Additionally, Western blot was applied to perform caspase 9
cleavage assay.
Results: When OA chondrocytes were exposed to ROS generators, mito-
chondrial dysfunction and apoptosis were accumulated as a consequence.
Pretreatment with TGF- beta preserved mitochondrial DNA integrity, ATP
levels, and restored drop in mitochondrial protein levels. Moreover, TGF-
beta enhanced chondrocytes viability and diminished the appearance of
apoptosis. The similar results were obtained for IL-1 beta and TNF-alpha.
Interestingly, TGF-beta did not have effect on nitric oxide levels enhanced
following pro-inﬂammatory cytokine exposure of chondrocytes.
Conclusions: The present results demonstrate for the ﬁrst time the mi-
toprotective properties of TGF-beta and offer additional explanation of
the mechanisms through which TGF-beta enhances cartilage repair. More
studies required evaluating more precisely the observed TGF- beta effects.
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Purpose: The cartilage growth plate regulates growth of endochondral
bones, and ectopic initiation of growth plate events (e.g. chondrocyte
hypertrophy) in articular chondrocytes contributes to the development of
osteoarthritis. MAPK signaling pathways have been implicated in different
aspects of growth plate development. In this study we focus on two
MAPK pathways: p38 and MEK/ERK. We analyzed the effects of these two
pathways on mouse growth plate chondrocyte gene expression and bone
growth in culture. Some of the speciﬁc roles of the p38 and MEK/ERK
pathways have been already investigated, but no study so far reported on
the effects of their simultaneous inhibition. We hypothesized that these
two signaling pathways have antagonizing roles in different aspects of the
growth plate development and the simultaneous inhibition will result in a
reduction of their speciﬁc effects.
Methods: RNA was isolated from mouse growth plate chondrocytes af-
ter 24 hours of culture in the presence of UO126 (MEK/ERK inhibitor),
SB202190 (p38 inhibitor) or DMSO (control) and hybridized to Affymetrix
MOE 430 2.0 gene chips (n = 3). The data were normalized and analyzed
using GeneSpring GX 7.3.1 and Ingenuity Pathway Analysis (IPA). The
expression of selected genes was conﬁrmed by real-time PCR. In addition,
mouse embryonic tibiae were cultured for 6 days in the presence of DMSO,
SB202190 (SB), UO126 (U) or SB202190+ UO126 (SU). Bone growth was
